Q6NRS1 AF NFT

Inhibitor of Bruton tyrosine kinase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibaw6c2k6nzhilyb6c7trvi6oco4fn2jghwdbcp5glwpg32qdjfu4/metadata.json
IPFS of structure file: 
bafybeieweu7cddz2ojjpur5e3q2zrxy5oiu3cjnevikml7tl44jwxgat7i/AF-Q6NRS1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x8579D35F9BDa0134778778b50BE4F4A1D75BBD52
First NFT owner address (bech32): 
genesis1s4uaxhummgqngau80z6she8558t4h02j59gvxq
Current NFT ID #183248 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
183248
Accession (UniProt):
Q6NRS1
Name::
Inhibitor of Bruton tyrosine kinase
Experimental Method:
Predicted structure
Sequence source:
XENOPUS LAEVIS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6NRS1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6NRS1|IBTK_XENLA Inhibitor of Bruton tyrosine kinase OS=Xenopus laevis OX=8355 GN=ibtk PE=2 SV=1 MERVWPECTTRCRSLQHALDVISVVTRASEQHIKVFLSSYCCNAVTLKDDFGRNATHIAASCGKKNVLDWLITGKGVDLAVKDKESGWTALHRSIFYGHIDCALSLLKHGSNLYIQDKDGYTPLDLVMKDRPPHIVFKTSDPTELYTWGDNVNFTLGHGTQQSKHHPELVEMFPRSGVYIKQMVLCKFHSVFLSQKGQVYTCGHGQGGRLGHGDELTCLVPRLVEGLRGHPCTQVAGAKDHTVVLTEDGYVYTFGLNTFHQLGIQPPPPNSNVPRQIQAKTMKGKTVLGVAAGRFHTVLWTKDAVYTVGLNGGQLGYLQDPNGEKFVSCPRQVSALHHKDINITLVSASDGATVCVSERGDIYLLSEYQCKKLASKQLNLKKVLVSGGILEHKAAPEHLKENGGQPASVFALDQAGRVFCWKSPGSSLKQCWWVYGRQLFMSDVALNKNEIMFVTQDGEGFTGKWMLEKKKKENTISNIMCHSDSQNVYEKISMQKLPFVHRAVSVATDPSGCNFAVLQSDPKTSLFEVPSVSSSVFAEDFEKLLNEANETDSIHDVTFQVGTKIFPAHKYILALRCDFFSKLFSSGEINSLDFPEVHQKGEDAAGCDLFVIEKIPPELFSHVLQFIYSDTCDMLLQGHKPKLWHKEENENTIICNFQKMGFREDIEGKSAYEVYKNSRICAENEKQKGKTKQSKKTRSIGDETSPVKMLQNTAKKFGLSNLSSRLDGVRYENGRINVFHKKSENKLRFNQKKCSSHYDVMMKSEDGKEFHCHKCVLCARLEYFNSMLSSSWIEASCCSQLEMPIHSDVLQVILDYIYTDEVLTVKESANVEFVCNVLVIADQLLIVRLKEICEVTIAERITLKNAAELLEFAALYNADQLKLSCLQFVGLNMGALLEARSLDVLSDDVLKDLSEAYRKMIPSMNKRIITPYLDGPDISILQSEDIESLISVQDDIYSYQITQEATLKKSKAKPKKKQRKRLDSSGGYNLSDIIQSPTSTGFVKPEKTNSVESLQDLLTSDSEGSFVGASSPRDLQSPDLFPVFTHETKETICVERNRSSPPVANGAASTKMPIPTTSSPKAIPMSRITPSTSPNWVAMPCSPASPVTMDLRAIMELEENIQKCGAMPKLNAGGTKPGTHVMKLSQKQRKMMAMSSKESNNENKPAKVTVAPTTIKSPAKTWAAAFHLGENKSFRDLLLEEKQSVTSFPSLSSDVKKSKHTEELDPSELARRPSGTLNQEAKLKCDVPNQDNSNPWHLTLSKNNASSAPVTFTAIVEEEEKQEAALIRSREKPLALIQIEERAIQDLLLHYQAIDNPEEYITIERAAQIPMATPMWNKH